Cargando…
The Impact of COVID-19 on Anxious and Depressive Symptomatology in the Postpartum Period
Background: Women in the postpartum period may be particularly vulnerable to the psychological effects of the COVID-19 pandemic. The aim of our study was to evaluate the impact of the coronavirus pandemic on postpartum depression and anxiety levels and the role of the fear of COVID-19 in its develop...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265928/ https://www.ncbi.nlm.nih.gov/pubmed/35805494 http://dx.doi.org/10.3390/ijerph19137833 |
_version_ | 1784743336618229760 |
---|---|
author | Pereira, Daniela Wildenberg, Brigite Gaspar, Andreia Cabaços, Carolina Madeira, Nuno Macedo, António Pereira, Ana Telma |
author_facet | Pereira, Daniela Wildenberg, Brigite Gaspar, Andreia Cabaços, Carolina Madeira, Nuno Macedo, António Pereira, Ana Telma |
author_sort | Pereira, Daniela |
collection | PubMed |
description | Background: Women in the postpartum period may be particularly vulnerable to the psychological effects of the COVID-19 pandemic. The aim of our study was to evaluate the impact of the coronavirus pandemic on postpartum depression and anxiety levels and the role of the fear of COVID-19 in its development. Methods: Women who delivered at the Bissaya Barreto Maternity Hospital, between 16 March and 16 June 2020 (Group 1: Birth in COVID-19 period, n = 207), recruited in the postpartum period, filled in a set of self-reported validated questionnaires: Perinatal Depression Screening Scale, Perinatal Anxiety Screening Scale, Profile of Mood States, Perseverative Thinking Questionnaire, Dysfunctional Beliefs Towards Maternity Scale, and the Fear of COVID-19 Scale. Levels of depressive and anxious symptomatology, negative affect, negative repetitive thinking, and the dysfunctional beliefs towards motherhood of these women were compared with data from samples of previous studies that included women whose delivery had occurred at the same Maternity Hospital before the COVID-19 pandemic period (Group 2: Birth before the COVID-19 period, n = 212). Results: Based on the cutoff points of the screening scales, the prevalence of clinically relevant depressive and anxious symptoms in Group 1 was 40.1% and 36.2%, respectively. Women in Group 1 had significantly higher levels of anxious and depressive symptoms, negative affect, negative repetitive thinking, and dysfunctional beliefs towards motherhood than women in Group 2 (p < 0.05). Fear of COVID-19 in the postpartum period was a predictor of depressive (ß = 0.262) and anxious (ß = 0.371) symptoms, explaining 6.9% and 13.7% of their variability, respectively (p < 0.001). Conclusion: During the COVID-19 pandemic, women in the postpartum period present greater depressive and anxious symptomatology, as well as increased risk factors. |
format | Online Article Text |
id | pubmed-9265928 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92659282022-07-09 The Impact of COVID-19 on Anxious and Depressive Symptomatology in the Postpartum Period Pereira, Daniela Wildenberg, Brigite Gaspar, Andreia Cabaços, Carolina Madeira, Nuno Macedo, António Pereira, Ana Telma Int J Environ Res Public Health Article Background: Women in the postpartum period may be particularly vulnerable to the psychological effects of the COVID-19 pandemic. The aim of our study was to evaluate the impact of the coronavirus pandemic on postpartum depression and anxiety levels and the role of the fear of COVID-19 in its development. Methods: Women who delivered at the Bissaya Barreto Maternity Hospital, between 16 March and 16 June 2020 (Group 1: Birth in COVID-19 period, n = 207), recruited in the postpartum period, filled in a set of self-reported validated questionnaires: Perinatal Depression Screening Scale, Perinatal Anxiety Screening Scale, Profile of Mood States, Perseverative Thinking Questionnaire, Dysfunctional Beliefs Towards Maternity Scale, and the Fear of COVID-19 Scale. Levels of depressive and anxious symptomatology, negative affect, negative repetitive thinking, and the dysfunctional beliefs towards motherhood of these women were compared with data from samples of previous studies that included women whose delivery had occurred at the same Maternity Hospital before the COVID-19 pandemic period (Group 2: Birth before the COVID-19 period, n = 212). Results: Based on the cutoff points of the screening scales, the prevalence of clinically relevant depressive and anxious symptoms in Group 1 was 40.1% and 36.2%, respectively. Women in Group 1 had significantly higher levels of anxious and depressive symptoms, negative affect, negative repetitive thinking, and dysfunctional beliefs towards motherhood than women in Group 2 (p < 0.05). Fear of COVID-19 in the postpartum period was a predictor of depressive (ß = 0.262) and anxious (ß = 0.371) symptoms, explaining 6.9% and 13.7% of their variability, respectively (p < 0.001). Conclusion: During the COVID-19 pandemic, women in the postpartum period present greater depressive and anxious symptomatology, as well as increased risk factors. MDPI 2022-06-26 /pmc/articles/PMC9265928/ /pubmed/35805494 http://dx.doi.org/10.3390/ijerph19137833 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pereira, Daniela Wildenberg, Brigite Gaspar, Andreia Cabaços, Carolina Madeira, Nuno Macedo, António Pereira, Ana Telma The Impact of COVID-19 on Anxious and Depressive Symptomatology in the Postpartum Period |
title | The Impact of COVID-19 on Anxious and Depressive Symptomatology in the Postpartum Period |
title_full | The Impact of COVID-19 on Anxious and Depressive Symptomatology in the Postpartum Period |
title_fullStr | The Impact of COVID-19 on Anxious and Depressive Symptomatology in the Postpartum Period |
title_full_unstemmed | The Impact of COVID-19 on Anxious and Depressive Symptomatology in the Postpartum Period |
title_short | The Impact of COVID-19 on Anxious and Depressive Symptomatology in the Postpartum Period |
title_sort | impact of covid-19 on anxious and depressive symptomatology in the postpartum period |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265928/ https://www.ncbi.nlm.nih.gov/pubmed/35805494 http://dx.doi.org/10.3390/ijerph19137833 |
work_keys_str_mv | AT pereiradaniela theimpactofcovid19onanxiousanddepressivesymptomatologyinthepostpartumperiod AT wildenbergbrigite theimpactofcovid19onanxiousanddepressivesymptomatologyinthepostpartumperiod AT gasparandreia theimpactofcovid19onanxiousanddepressivesymptomatologyinthepostpartumperiod AT cabacoscarolina theimpactofcovid19onanxiousanddepressivesymptomatologyinthepostpartumperiod AT madeiranuno theimpactofcovid19onanxiousanddepressivesymptomatologyinthepostpartumperiod AT macedoantonio theimpactofcovid19onanxiousanddepressivesymptomatologyinthepostpartumperiod AT pereiraanatelma theimpactofcovid19onanxiousanddepressivesymptomatologyinthepostpartumperiod AT pereiradaniela impactofcovid19onanxiousanddepressivesymptomatologyinthepostpartumperiod AT wildenbergbrigite impactofcovid19onanxiousanddepressivesymptomatologyinthepostpartumperiod AT gasparandreia impactofcovid19onanxiousanddepressivesymptomatologyinthepostpartumperiod AT cabacoscarolina impactofcovid19onanxiousanddepressivesymptomatologyinthepostpartumperiod AT madeiranuno impactofcovid19onanxiousanddepressivesymptomatologyinthepostpartumperiod AT macedoantonio impactofcovid19onanxiousanddepressivesymptomatologyinthepostpartumperiod AT pereiraanatelma impactofcovid19onanxiousanddepressivesymptomatologyinthepostpartumperiod |